KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $26.4 million.

  • Cme's Depreciation & Amortization (CF) fell 638.3% to $26.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.0 million, marking a year-over-year decrease of 689.66%. This contributed to the annual value of $115.1 million for FY2024, which is 865.08% down from last year.
  • As of Q3 2025, Cme's Depreciation & Amortization (CF) stood at $26.4 million, which was down 638.3% from $27.3 million recorded in Q2 2025.
  • In the past 5 years, Cme's Depreciation & Amortization (CF) ranged from a high of $37.6 million in Q1 2021 and a low of $26.4 million during Q3 2025
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $31.9 million (2023), whereas its average is $31.7 million.
  • In the last 5 years, Cme's Depreciation & Amortization (CF) soared by 651.56% in 2021 and then plummeted by 1114.55% in 2024.
  • Cme's Depreciation & Amortization (CF) (Quarter) stood at $37.2 million in 2021, then decreased by 7.26% to $34.5 million in 2022, then dropped by 9.86% to $31.1 million in 2023, then fell by 9.32% to $28.2 million in 2024, then decreased by 6.38% to $26.4 million in 2025.
  • Its Depreciation & Amortization (CF) was $26.4 million in Q3 2025, compared to $27.3 million in Q2 2025 and $27.3 million in Q1 2025.